ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 105 filers reported holding ANTARES PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $513,000 | +15.0% | 125,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $446,000 | -2.0% | 125,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $455,000 | -16.5% | 125,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $545,000 | +6.0% | 125,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $514,000 | +3.0% | 125,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $499,000 | +47.6% | 125,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $338,000 | -1.7% | 125,000 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $344,000 | +16.6% | 125,000 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $295,000 | -49.8% | 125,000 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $588,000 | +40.7% | 125,000 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $418,000 | +1.7% | 125,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $411,000 | +8.4% | 125,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $379,000 | +11.5% | 125,000 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $340,000 | -19.0% | 125,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $420,000 | +30.0% | 125,000 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $323,000 | +17.5% | 125,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $275,000 | +10.4% | 125,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $249,000 | -38.5% | 125,000 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $405,000 | +0.5% | 125,000 | 0.0% | 0.00% | -33.3% |
Q2 2017 | $403,000 | +13.5% | 125,000 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $355,000 | +22.0% | 125,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $291,000 | +20.2% | 125,000 | -13.2% | 0.00% | 0.0% |
Q3 2016 | $242,000 | -27.3% | 144,000 | -47.6% | 0.00% | -33.3% |
Q4 2015 | $333,000 | -28.8% | 275,000 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $468,000 | -18.2% | 275,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $572,000 | -23.2% | 275,000 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $745,000 | +5.4% | 275,000 | 0.0% | 0.01% | +20.0% |
Q4 2014 | $707,000 | +39.4% | 275,000 | -0.7% | 0.01% | +25.0% |
Q3 2014 | $507,000 | -31.5% | 277,000 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $740,000 | -26.8% | 277,000 | 0.0% | 0.01% | -33.3% |
Q1 2014 | $1,011,000 | – | 277,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |